Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129473) titled 'Hyperemesis Gravidarum Risk Reduction With Metformin' on Aug. 7.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: University of Southern California

Condition: Hyperemesis Gravidarum

Intervention: Drug: Metformin Extended Release Oral Tablet

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 2025

Target Sample Size: 224

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07129473

Published by HT Digital Content Services with permi...